UPL Corporation acquires Arysta LifeScience
Together, UPL and Arysta will form a new company with complete offerings in a wide range of crops. The transaction is expected to close in late 2018 or early 2019.
Under Platform’s ownership, Arysta has grown to a global scale through a series of complementary acquisitions, doubling the peak sales value potential of its R&D pipeline, focusing the business on high value specialty applications.
With the complementary combination of UPL’s active ingredient manufacturing competence and Arysta’s R&D and technology partnerships, the new company will be in the position to provide growers with complete, competitive and differentiated solutions, thereby becoming a “one-stop-shop” supplier to customers in key agricultural markets, according to Arysta. The combined business is set to boost its market access, strengthen distribution networks and reach millions of farmers in more than 100 countries.